Abciximab biosimilar (ISU Abxis)

阿昔单抗生物类似物 (ISU Abxis)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAbciximab biosimilar (ISU Abxis)

Drug Alias Name阿昔单抗生物仿制药 (ISU Abxis)Abciximab (ISU Abxis)阿布赛昔单抗生物仿制药 (ISU Abxis)Abciximabum (ISU Abxis)阿西单抗生物仿制药 (ISU Abxis) +[8]

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Fab fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyBiologics > Biosimilar

Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists

TargetsIntegrin alpha-IIb/beta-3

Therapy Area/IndicationsMyocardial InfarctionMyocardial Ischemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesIsu Abxis Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesIsu Abxis Co Ltd

Inactive CompaniesN/A

Active IndicationsMyocardial InfarctionMyocardial Ischemia

Inactive IndicationsN/A

Other Information

ATC CodeB01AC13